Virtual Medicinal Product (VMP)
-
Agalsidase alfa 1mg/1ml solution for infusion vials
Name Details
Current Name
Agalsidase alfa 1mg/1ml solution for infusion vials
|
Start Date
13-01-2009
|
End Date
|
Previous Name
Agalsidase alfa 1mg/1ml solution for injection vials
|
Start Date
23-09-2005
|
End Date
12-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A16AB03
BNF |
Current BNF
09080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
09080100
|
Start Date
11-10-2006
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
9552211000001105 |
23-09-2005 |
|
VMP Ingredients
VMP ingredients table
Agalsidase alfa |
Based on Ingredient Substance |
|
1 mg |
1 ml |
Name
Agalsidase alfa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
1
Virtual Medicinal Product Pack (VMPP) Information